Johnson & Johnson (JNJ)
CDs Offer Certainty. Dividend Stocks Offer Something Retirees May Need More
When a retiree compares a federally insured CD to a dividend stock that has raised its payout for 70 straight years, the choice turns on a factor most income calculators ignore entirely.
3 Dividend Stocks Built for Retirement to Buy in September
Retirement portfolios need income that shows up on time, grows faster than inflation, and does not blink during a downturn.
J&J Up 18% in Three Months: Buy, Sell or Hold the Stock?
JNJ's growth gets a boost from new drug launches and pipeline wins, but Stelara's patent loss and MedTech headwinds remain key risks.
Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know
In the most recent trading session, Johnson & Johnson (JNJ) closed at $270.22, indicating a +1.1% shift from the previous trading day.
Johnson & Johnson (JNJ) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
Johnson & Johnson (JNJ) Presents at Deutsche Bank 2026 Healthcare Summit Transcript
Johnson & Johnson Sees Path to Double-Digit Growth Despite 2026 Patent Cliff
Johnson & Johnson NYSE: JNJ Executive Vice President and Chief Financial Officer Joe Wolk said the company sees a path to growth above its previously stated 5% to 7% long-term range, supported by its pharmaceutical pipeline, medical technology portfolio and capital flexibility.
Monthly Paydays vs. Compound Growth: Why JNJ Beats O for Long-Term Retirees
Realty Income pays you every month while Johnson and Johnson barely clears 2% yield, yet one of these retirement staples is quietly demolishing the other where it counts most for a 20-year income plan.
3 Healthcare Stocks for 3 Stages of Life
When it comes to investing, there is no one-size-fits-all approach. Strategies vary based on numerous factors, including but not limited to investors' risk tolerance, net worth, and age.
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Johnson & Johnson (JNJ). This makes it worthwhile to examine what the stock has in store.
3 Dividend Stocks Baby Boomers Should Own for the Rest of Their Lives
Retirees don't need the highest yield on the board. They need the check to keep arriving, and to keep growing, through every recession, rate cycle, and regime change.
Johnson & Johnson Targets Double-Digit Growth as STELARA Faces Biosimilar Competition
Johnson & Johnson NYSE: JNJ executives said the company remains on track to grow through biosimilar competition for STELARA and expects its portfolio of medicines, medical devices and pipeline programs to support accelerating growth through the end of the decade.
Why Johnson & Johnson (JNJ) is a Top Dividend Stock for Your Portfolio
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes?
